Search Results - "Lim, Sheau Chin"
-
1
Curcumin and a hemi‐analogue with improved blood–brain barrier permeability protect against amyloid‐beta toxicity in Caenorhabditis elegans via SKN‐1/Nrf activation
Published in Journal of pharmacy and pharmacology (01-05-2019)“…Objectives This study aims to investigate the blood–brain barrier (BBB) permeability of curcumin analogues with shortened linkers and their ability to protect…”
Get full text
Journal Article -
2
Pharmacometabolomics analysis of plasma to phenotype clopidogrel high on treatment platelets reactivity in coronary artery disease patients
Published in European journal of pharmaceutical sciences (30-05-2018)“…Dual antiplatelet therapy (DAPT) of clopidogrel and aspirin is crucial for coronary artery disease (CAD) patients undergoing percutaneous coronary intervention…”
Get full text
Journal Article -
3
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
Published in Cardiology Research and Practice (01-01-2017)“…Dual antiplatelet therapy of aspirin and clopidogrel is pivotal for patients undergoing percutaneous coronary intervention. However, the variable platelets…”
Get full text
Journal Article -
4
Formulation and In Vivo Evaluation of a Solid Self-Emulsifying Drug Delivery System Using Oily Liquid Tocotrienols as Model Active Substance
Published in Pharmaceutics (25-10-2021)“…Self-emulsifying drug delivery systems (SEDDS) can improve the oral bioavailability of poorly water-soluble drugs. Solid self-emulsifying drug delivery systems…”
Get full text
Journal Article -
5
The effect of CYP2C19 genetic polymorphism and non-genetic factors on clopidogrel platelets inhibition in East Asian coronary artery disease patients
Published in Thrombosis research (01-10-2017)“…[Display omitted] •Clopidogrel HTPR is frequent among East Asians, regardless of using high LD.•CYP2C19*2 and obesity are associated with clopidogrel HTPR,…”
Get full text
Journal Article -
6
1H NMR based pharmacometabolomics analysis of urine identifies metabolic phenotype of clopidogrel high on treatment platelets reactivity in coronary artery disease patients
Published in Journal of pharmaceutical and biomedical analysis (30-11-2017)“…[Display omitted] •We analysed patients’ urine samples before and after the administration of 600mg clopidogrel loading dose using 1H NMR.•Multivariate…”
Get full text
Journal Article -
7
TCT-841 Integrative Pharmacometabonomics-Pharmacogenetics approach to predict clopidogrel response in Coronary Artery Disease (CAD) patients undergoing Interventional Angiographic Procedure (IAP)
Published in Journal of the American College of Cardiology (31-10-2017)“…Nuclear magnetic resonance spectroscopy (NMR) pharmacometabonomics analysis has been used to predict drug response. Methods 71 coronary artery disease (CAD)…”
Get full text
Journal Article -
8
The CYP2C191/2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
Published in Cardiology Research and Practice (2013)“…Background. The CYP2C19*2 allele may be associated with a reduced antiplatelet effect for clopidogrel. Here, we assessed whether CYP2C19*2 alleles correlate…”
Get full text
Journal Article -
9
The CYP2C19(∗)1/(∗)2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
Published in Cardiology research and practice (2013)“…Background. The CYP2C19∗2 allele may be associated with a reduced antiplatelet effect for clopidogrel. Here, we assessed whether CYP2C19∗2 alleles correlate…”
Get full text
Journal Article -
10
Formulation of oily tocotrienols as a solid self-emulsifying dosage form for improved oral bioavailability in human subjects
Published in Journal of drug delivery science and technology (01-10-2022)“…Self-emulsifying drug delivery systems (SEDDS) have been shown to enhance the water-solubility and oral bioavailability of poorly water-soluble compound. Solid…”
Get full text
Journal Article -
11
Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A Randomized Clinical Trial
Published in JAMA neurology (01-04-2018)“…Management of painful diabetic peripheral neuropathy remains challenging. Most therapies provide symptomatic relief with varying degrees of efficacy…”
Get more information
Journal Article -
12
Effect of Food Status on the Gastrointestinal Transit of Amphotericin B-Containing Solid Lipid Nanoparticles in Rats
Published in AAPS PharmSciTech (01-10-2016)“…Amphotericin B (AmB) is poorly absorbed from the gastrointestinal tract. Recent studies have suggested enhanced drug absorption from solid lipid nanoparticles…”
Get full text
Journal Article -
13
1 H NMR based pharmacometabolomics analysis of urine identifies metabolic phenotype of clopidogrel high on treatment platelets reactivity in coronary artery disease patients
Published in Journal of pharmaceutical and biomedical analysis (30-11-2017)“…Clopidogrel high on treatment platelets reactivity (HTPR) has burdened achieving optimum therapeutic outcome. Although there are known genetic and non-genetic…”
Get full text
Journal Article -
14
TCTAP A-126 The Identification of Novel Biomarkers of Clopidogrel High on Treatment Platelets Reactivity Using Pharmacometabonomics Analysis of Plasma in Coronary Artery Disease Patients
Published in Journal of the American College of Cardiology (26-04-2016)“…Methods Blood samples of 71 coronary artery disease (CAD) patients planned for interventional angiographic procedure were collected prior to loading with…”
Get full text
Journal Article -
15
A Gastrointestinal Transit Study on Amphotericin B-Loaded Solid Lipid Nanoparticles in Rats
Published in AAPS PharmSciTech (01-08-2015)“…The gastrointestinal (GI) transit behavior of and absorption from an amphotericin B (AmB) solid lipid nanoformulation (SLN) in rats was investigated. We aimed…”
Get full text
Journal Article -
16
PHARMACOMETABONOMICS ANALYSIS OF URINE TO PREDICT CLOPIDOGREL HIGH ON TREATMENT PLATELETS REACTIVITY (HTPR) IN CORONARY ARTERY DISEASE PATIENTS (CAD) UNDERGOING INTERVENTIONAL ANGIOGRAPHIC PROCEDURE
Published in Malaysian journal of pharmaceutical sciences (01-01-2015)“…Clopidogrel antiplatelet drug is limited by variable response among patients. This leads to poor patient outcome on treatment platelets reactivity (HTPR)…”
Get full text
Journal Article -
17
PHARMACOMETABONOMICS ANALYSIS OF PLASMA TO IDENTIFY NOVEL BIOMARKERS OF CLOPIDOGREL HIGH ON TREATMENT PLATELETS REACTIVITY (HTPR)
Published in Malaysian journal of pharmaceutical sciences (01-01-2015)“…Prescribing clopidogrel antiplatelet drug is mitigated by high on treatment platelets reactivity (HTPR) which might lead to therapeutic failure. The HTPR is…”
Get full text
Journal Article -
18
The [CYP2C19.sup.] [1/.sup.]2 genotype does not adequately predict clopidogrel response in healthy Malaysian volunteers
Published in Cardiology research and practice (01-01-2013)“…Background. The [CYP2C19.sup.*] 2 allele may be associated with a reduced antiplatelet effect for clopidogrel. Here, we assessed whether [CYP2C19.sup.*] 2…”
Get full text
Journal Article